3-乙酰基-7-羟基香豆素衍生物的设计、合成及抗血小板聚集活性OA北大核心CSTPCD
Design,synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives
为寻找安全有效的抗血小板聚集药物,以间苯二酚为起始原料,经Vilsmeier-Haack反应、Knoevenagel反应制备先导化合物 3-乙酰基-7-羟基-香豆素;再对其 7-位羟基进行氨基烷基醚化,3-位酮羰基肟化,得到 25个目标化合物(6a~6y).所合成的目标化合物的结构经过高分辨质谱、核磁共振氢谱和红外光谱确证.采用Bron比浊法分别测试了目标化合物对二磷酸腺苷(ADP)、胶原、花生四烯酸(AA)和凝血酶诱导的血小板聚集的抑制作用.结果表明,合成的目标化合物对 4种诱导剂诱导的血小板聚集均具有一定的抑制活性,部分化合物的活性远优于阳性对照药阿司匹林.其中,目标化合物 6a、6b对4种诱导剂诱导的血小板聚集均有较强的抑制活性,且具有较好的水溶性和脂水分配系数(溶解度为 3.46和 3.85 mg/mL,脂水分配系数为2.56和2.85),有望成为具有多靶点抗血小板聚集作用的临床前候选化合物.
In order to search for coumarin-based anti-platelet aggregation compounds with high efficacy and good druggability,twenty-five 3-acetyl-7-hydroxy-coumarin oxime derivatives(6a-6y)were synthesized via Vilsmeier-Haack reaction,Knoevenagel reaction,Williamson reaction,electrophilic substitution reaction and oximation reaction from resorcinol.Their structures were confirmed by HRMS and 1H NMR spectra.The anti-platelet aggregation activity of the target compounds was evaluated using Born's turbidimetric method.The results revealed that most of them could significantly inhibit platelet aggregation induced by adenosine diphosphate(ADP),collagen,arachidonic acid(AA)and thrombin.Among them,the target compounds 6a and 6b not only had strong inhibitory activity on platelet aggregation induced by the four inducers,but also exhibited good water solubility(3.46 mg/mL and 3.85 mg/mL,respectively)and lipid-water partition coefficient(2.56 and 2.85,respectively)and were expected to become a preclinical candidate compound with multi-target action against platelet aggregation.
尚飞扬;刘成波;谭鸿舟;何冰;何黎琴
安徽中医药大学药学院,合肥 230038
药学
3-乙酰基-7-羟基-香豆素肟水溶性抗血小板聚集
3-acetyl-7-hydroxy-coumarinoximeaqueous solubilityanti-platelet aggregation
《中国药科大学学报》 2024 (003)
367-374 / 8
This study was supported by the Natural Science Foundation of Department of Education of Anhui Province(No.KJ2020A0957,No.KJ2021B003) 安徽省教育厅自然科学科研项目(No.KJ2020A0957,No.KJ2021B003)
评论